Sanj K Patel Insider Trading
Get free email notifications about insider trading for Sanj K Patel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sanj K Patel. Sanj K Patel is a Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a President & CEO in SYNAGEVA BIOPHARMA CORP ($GEVA) and a Director in Syros Pharmaceuticals, Inc. ($SYRS) and a Chairman & CEO in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
Address: SYNAGEVA BIOPHARMA 128 SPRING STREET LEXINGTON 02421 MA
Companies in which Sanj K Patel is an Insider
BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sanj K Patel: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 25 2017
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kiniksa Pharmaceuticals, Ltd.
Trading Symbol: KNSAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sanj K Patel: Chairman & CEO
Holdings: 4,924 shares
Latest Transaction: Mar 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Trading Symbol: GEVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sanj K Patel: President & CEO
Holdings: 0 shares
Latest Transaction: Jun 23 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Trading Symbol: SYRSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sanj K Patel: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 12 2017
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sanj K Patel
Sentiment: All, BCRX, KNSA, GEVA, SYRS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 0.00 | 12,002 | 0 | 12,002 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 0.00 | 18,555 | 0 | 18,555 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 0.00 | 26,276 | 0 | 26,276 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 22.89 | 157,658 | 3,608,792 | 157,658 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 1,600 | 2,544 | 325,271 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 20,401 | 32,438 | 326,871 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 4,924 | 7,829 | 347,272 |